Hg Capital Acquires Majority Stake in Intelerad: The Signify View

Steve Holloway headshot
Steve Holloway
Published: February 11, 2020 In The News

10th February 2020 – Written by Steve Holloway – Featured on Healthcare Business Euro News – After a relatively short search, Intelerad has found a new majority stakeholder, Hg Capital. The London, UK-based investment firm has already invested over $1B in the healthcare and life sciences sector, including firms such as Rhapsody and Corepoint (healthcare data interoperability) , Allocate Software (healthcare workforce management), Evaluate (Pharmaceutical commercial information and advisory) and Medifox (ambulatory are services). The deal is expected to close by the end of 1Q 2020, providing Intelerad with a substantial new investor and war chest. So what will Intelerad do with the new funds and what challenges lie ahead?